Cambridge Investment Research Advisors, Inc. Mannkind Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$3.61 - $5.45 $37,168 - $56,113	-10,296 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$3.14 - $6.14 $94,243 - $184,285	-30,014 Reduced 74.46%	10,296 $40,000
Q4 2020 Feb 04, 2021	BUY	$1.79 - $4.04 $4,942 - $11,154	2,761 Added 7.35%	40,310 $126,000
Q3 2020 Oct 29, 2020	SELL	$1.56 - $2.08 $842 - $1,123	-540 Reduced 1.42%	37,549 $70,000
Q2 2020 Jul 27, 2020	SELL	$0.94 - $2.21 $1,473 - $3,465	-1,568 Reduced 3.95%	38,089 $66,000
Q4 2019 Feb 04, 2020	SELL	$1.14 - $1.49 $5,813 - $7,599	-5,100 Reduced 11.39%	39,657 $51,000
Q3 2019 Nov 06, 2019	SELL	$1.04 - $1.44 $1,164 - $1,612	-1,120 Reduced 2.44%	44,757 $55,000
Q2 2019 Aug 15, 2019	SELL	$1.09 - $1.88 $6,289 - $10,847	-5,770 Reduced 11.17%	45,877 $0
Q1 2019 May 08, 2019	SELL	$1.14 - $2.25 $4,286 - $8,460	-3,760 Reduced 6.79%	51,647 $0
Q4 2018 Feb 05, 2019	BUY	$1.02 - $2.05 $37,427 - $75,222	36,694 Added 196.09%	55,407 $58,000
Q3 2018 Nov 02, 2018	BUY	$1.01 - $2.19 $19 - $41	19 Added 0.1%	18,713 $0
Q2 2018 Aug 10, 2018	SELL	$1.59 - $2.38 $1,272 - $1,904	-800 Reduced 4.1%	18,694 $0
Q1 2018 May 09, 2018	SELL	$2.28 - $3.8 $6,443 - $10,738	-2,826 Reduced 12.66%	19,494 $0
Q4 2017 Feb 22, 2018	SELL	$2.28 - $6.71 $4,726 - $13,909	-2,073 Reduced 8.5%	22,320 $0
Q2 2017 Aug 08, 2017	BUY	N/A	24,393	24,393 $34,000

Others Institutions Holding MNKD

# of Institutions

242

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account